x NoneEntity Type
0001553846
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 RedHill Biopharma Ltd.
Jurisdiction of Incorporation/OrganizationISRAEL 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 RedHill Biopharma Ltd. 
Street Address 1Street Address 2
 21 HA'ARBA'A STREET 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 TEL AVIV ISRAEL 6473921 972-3-541-3131 



3. Related Persons
Last NameFirst NameMiddle Name
Ben-AsherDror
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
SwendenEric
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ReedKenneth
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
TsimchiOfer
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
CabillyShmuel
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ScruggsRickD
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
WeinsteinNicolas
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
FelderAlla
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
Ben ChorinMicha
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
FrishAdi
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
RadayGilead
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
GoldbergGuy
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
FathiReza
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
AlmenoffJune
Street Address 1Street Address 2
21 HA'ARBA'A STREET
CityState/Province/CountryZIP/Postal Code
TEL AVIVISRAEL6473921
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
x $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
o Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2019-10-22 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 48300000 USD o Indefinite
Total Amount Sold $ 48300000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 A portion of the ADSs were issued at an agreed value of $12 million, as an upfront payment for rights granted to the issuer under an exclusive license agreement


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 2


15. Sales Commissions & Finders' Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Redhill Biopharma Charts.
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Redhill Biopharma Charts.

Redhill Biopharma Ltd. News

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
Wednesday 24 April 2024 (1 week ago) • PR Newswire (US)
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Monday 8 April 2024 (4 weeks ago) • PR Newswire (US)
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
Tuesday 2 April 2024 (1 month ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
RedHill Announces New USPTO Patent Covering Talicia® Through 2034
Monday 11 March 2024 (2 months ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
Tuesday 5 March 2024 (2 months ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
Tuesday 20 February 2024 (2 months ago) • PR Newswire (US)
Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

More Redhill Biopharma Ltd. News Articles